Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Fast Is The Diabetic Peripheral Neuropathy Market Expected to Grow Between 2025 And 2029?
There has been a robust growth in the market size of diabetic peripheral neuropathy in the past few years. The market value is projected to increase from $3.51 billion in 2024 to $3.83 billion in 2025, showing a compound annual growth rate (CAGR) of 9.1%. Factors leading to this upward trend during the historical period include a growing elderly population, increased diabetes cases, expanding healthcare spending, heightened awareness of diabetes-related complications, and a rise in healthcare resources.
The market size for diabetic peripheral neuropathy is forecasted to exhibit robust growth in the coming years, reaching a worth of$5.39 billion by 2029″, progressing at a compound annual growth rate (CAGR) of 8.9%. This expansion in the projected period can be associated with a rise in inactive lifestyles, amplified government initiatives and funding, escalating prevalence of risk factors associated with neuropathy, increased diagnostic precision, and heightened emphasis on early detection and prevention measures. Prevalent trends within the estimation period incorporate developments in diagnostic technologies, advancements in treatment methodologies, greater allocation in research and development, the advent of minimally invasive procedures, and a reinforced focus on collaborative research and development.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21170&type=smp
Which Primay Drivers Are Accelerating Growth in the Diabetic Peripheral Neuropathy Market?
The surge in health problems related to obesity is anticipated to stimulate the expansion of the diabetic peripheral neuropathy market. Obesity, characterized by an excess accumulation of body fat, can negatively impact health and heighten the risk for various long-term diseases. The escalation in health complications stemming from obesity can be attributed to increased awareness, modifications in lifestyle, and a rising demand for preventative and treatment strategies, thus escalating the need for healthcare. Diabetic peripheral neuropathy is beneficial in the control of obesity, offering vital knowledge about nerve damage resulting from obesity-related conditions, and directing custom treatments to enhance patient wellness and life quality. For example, as per data from the World Health Organization (WHO), an agency of the United Nations based in Switzerland tasked with worldwide public health, in March 2024, it was revealed that 43% of adults over the age of 18 were classed as overweight, and 16% were living with obesity in 2022. Additionally, 37 million children below the age of 5 were considered overweight. Among children and adolescents aged between 5 and 19 years, over 390 million were overweight, with 160 million suffering from obesity. Hence, the growth in health issues related to obesity is contributing to the expansion of the diabetic peripheral neuropathy market.
Which Primary Segments of the Diabetic Peripheral Neuropathy Market Are Driving Growth and Industry Transformations?
The diabetic peripheral neuropathymarket covered in this report is segmented –
1) By Disease: Type 2 Diabetic Peripheral Neuropathy; Type 1 Diabetic Peripheral Neuropathy
2) By Treatment: Pain Management Drugs; Gene Therapies
3) By Therapy: Antidepressants; Anticonvulsants
4) By Patient Population: Adult Patients; Geriatric Patients
Subsegments:
1) By Type 2 Diabetic Peripheral Neuropathy: Sensory Neuropathy; Motor Neuropathy; Autonomic Neuropathy
2) By Type 1 Diabetic Peripheral Neuropathy: Distal Symmetric Neuropathy; Mononeuropathy; Polyradiculopathy
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21170&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Diabetic Peripheral Neuropathy Market?# Market?
North America was the largest region in the diabetic peripheral neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic peripheral neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Diabetic Peripheral Neuropathy Industry Dynamics?
In the diabetic peripheral neuropathy market, predominant companies are turning their attention towards technological breakthroughs such as NaV1.8 pain signal inhibitors, with the aim of delivering superior, non-opioid treatment options that enhance pain control and overall life quality for patients. NaV1.8 pain signal inhibitors are specialized medications that obstruct the NaV1.8 sodium channel, a critical conduit of pain signals in sensory neurons, enabling the alleviation of acute and neuropathic pain without dependence on opioids. To illustrate, Vertex Pharmaceuticals Incorporated, a biotech organization based in the US, in April 2024, made progress in its suzetrigine pain program. The progress includes the initialization of a Phase 3 crucial program to treat pain linked with diabetic peripheral neuropathy (DPN). Suzetrigine, a selective NaV1.8 pain signal inhibitor, has demonstrated encouraging outcomes in preliminary studies and has recently earned a breakthrough therapy designation for diabetic Peripheral Neuropathy (DPN) pain control from the Food and Drug Administration (FDA), a federal agency based in the US.
View the full report here:
What Parameters Are Used to Define the Diabetic Peripheral Neuropathy Market?
Diabetic Peripheral Neuropathy (DPN) is a nerve disorder caused by prolonged high blood sugar levels in individuals with diabetes, leading to nerve damage primarily in the legs, feet, arms, and hands. This condition occurs due to long-term high blood sugar levels, which damage the nerves and blood vessels, impairing nerve function and blood flow to the affected areas.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21170
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model